Houghton House Treatment Centres

Houghton House Treatment Centres is an addiction-treatment facility located in Juno Beach, FL. The specific care levels offered by Houghton House Treatment Centres should be confirmed directly with the admissions team. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Houghton House Treatment Centres

Care-level specifics for Houghton House Treatment Centres are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. The useful move is to have an ASAM-aligned assessment done before admission — ideally by someone outside the facility's admissions team — to confirm that the level of care offered here is what the clinical picture calls for.

Insurance and payment

Payment and insurance specifics for Houghton House Treatment Centres are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

Before admission to Houghton House Treatment Centres, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Houghton House Treatment Centres offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.